Drop Nora into Claude and get a Senior Medical Writer who translates complex clinical and scientific information into accurate, appropriately formatted content - regulatory submissions, journal manuscripts, clinical trial documentation, HTA dossiers, patient information leaflets, CME materials, and plain language summaries across every medical writing format.
The same clinical trial data requires completely different writing for an EMA regulatory summary, a journal article, a conference abstract, a GP reference guide, and a patient leaflet. Nora is built for pharmaceutical companies, CROs, medical communications agencies, and freelance medical writers. She asks for target audience and document type before producing anything, never fabricates clinical data (missing values are [DATA TO BE PROVIDED] placeholders), and flags regulatory compliance requirements - while noting that final regulatory sign-off requires qualified regulatory affairs review.
What you get
-
→
Regulatory writing - Clinical Study Report (CSR) sections and narratives, Summary of Product Characteristics (SmPC) drafts, Patient Information Leaflet (PIL) and Instructions for Use (IFU), Investigator Brochure narratives, Risk Management Plan (RMP) narrative sections, and Common Technical Document (CTD) summaries meeting ICH E3, EMA, and FDA requirements
-
→
Clinical trial documentation - study protocol and protocol synopsis drafts, Statistical Analysis Plan (SAP) narrative sections, Informed Consent Form (ICF) drafts structured to Declaration of Helsinki and ICH E6(R3) GCP standards, Case Report Form (CRF) completion guidelines, and DSMB/IDMC charter sections
-
→
Publications and scientific communications - journal manuscript sections (introduction, methods, discussion) following CONSORT, PRISMA, and STROBE reporting standards, conference abstract drafts, systematic review and meta-analysis narrative sections, literature review sections, and responses to peer reviewer comments
-
→
Patient-facing materials and plain language summaries - plain language summaries of clinical trials for non-specialist audiences, disease awareness patient content, patient support programme materials, lay summaries of research, and patient information materials written to health literacy standards with GPP 2022 compliance awareness
-
→
Medical education materials - Continuing Medical Education (CME) content, slide deck scientific narrative, symposium and advisory board materials, disease awareness materials for HCPs, prescribing guide narratives, and healthcare professional training materials following ABPI Code of Practice (UK) standards
-
→
Health technology assessment and outcomes - NICE and SMC HTA dossier narrative sections, value dossier summaries, real-world evidence summaries, budget impact model narratives, and health economics evidence synthesis structured to meet HTA body submission requirements